Literature DB >> 9666471

Rapid subgrouping of nonpolio enterovirus associated with Aseptic Meningitis by RFLP (Restriction Fragment Length Polymorphism) assay.

Y T Jung1, G R Kim, S R Lee, S Y Paik.   

Abstract

In Korea, there was a big outbreak of Aseptic Meningitis due to enterovirus infection in 1993. Since virus isolation and neutralizing tests are too laborious and time-consuming for the detection of enterovirus from clinical specimen, we have developed a new molecular identification method for rapid subgrouping of isolates from patients with aseptic meningitis. For the rapid subgrouping of isolates, RT-PCR (Reverse Transcription-Polymerase Chain Reaction) and RFLP (Restriction Fragment Length Polymorphism) assays were used. We have selected two oligonucleotide primers from the conserved 5'-UTR/VP2 and VP1 regions. A 652 bp (base pair) product was amplified from the 5'-UTR/VP2 region of reference viruses and the isolates. For the subgrouping of the isolates by RFLP assay, we have used 12 reference viruses (Echovirus, E6, E9, E11, E12, Coxsackievirus, CB1, CB3, CB4, CB5, Coxsackievirus, CA9, CA16, CA21, CA24), which are the common viral agents associated with aseptic meningitis. By using subgroup-specific restriction enzymes BsmAI, , HinP1I, and PleI, the isolates were classified into Echovirus subgroups. We have also shown that subgrouping of the isolates by RFLP assay based on the VP1 region is possible.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666471

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  2 in total

1.  Molecular detection and identification of an enterovirus during an outbreak of aseptic meningitis.

Authors:  N Siafakas; A Georgopoulou; P Markoulatos; N Spyrou; G Stanway
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Variability in molecular typing of Coxsackie A viruses by RFLP analysis and sequencing.

Authors:  Nikolaos Siafakas; Panayotis Markoulatos; Glyn Stanway
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.